U.S. pays Pfizer, BioNTech $2 bln for vaccines

The U.S. government will pay $1.95 billion to buy 100 million doses of Pfizer's and German biotech firm BioNTech's COVID-19 vaccine candidate if they are able to successfully develop one, the companies said on Wednesday. Fred Katayama reports.

Multimedia

Most Popular Videos